日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantitative evaluation of (123)I-MIBG imaging in patients with myocarditis: impairment of cardiac neuronal function revisited

心肌炎患者(123)I-MIBG显像的定量评价:重新审视心脏神经元功能障碍

Kessler, Lukas; Settelmeier, Stephan; Pabst, Kim M; Telli, Tugce; Varasteh, Zohreh; Costa, Pedro Fragoso; Jentzen, Walter; Barbato, Francesco; Hautzel, Hubertus; Himmen, Stephan; Rischpler, Christoph; Rassaf, Tienush; Herrmann, Ken; Kersting, David

Sex-specific differences in cardiac transthyretin amyloidosis: addressing the diagnostic gap in women

心脏转甲状腺素蛋白淀粉样变性的性别差异:解决女性诊断差距问题

Vogel, Julia; Jura, Sophia; Settelmeier, Stephan; Lerchner, Tobias; Buehning, Florian; Yahsaly, Loubna; Carpinteiro, Alexander; Reinhardt, H Christian; Rassaf, Tienush; Michel, Lars

Delays in diagnosis and treatment of ATTR cardiac amyloidosis: A real-world data analysis

ATTR型心脏淀粉样变性诊断和治疗延误:一项真实世界数据分析

Vogel, Julia; Jura, Sophia; Settelmeier, Stephan; Buehning, Florian; Lerchner, Tobias; Carpinteiro, Alexander; Rassaf, Tienush; Michel, Lars

MultiOmicsAgent: Guided Extreme Gradient-Boosted Decision Trees-Based Approaches for Biomarker-Candidate Discovery in Multiomics Data

MultiOmicsAgent:基于引导式极端梯度提升决策树的多组学数据生物标志物候选发现方法

Settelmeier, Jens; Goetze, Sandra; Boshart, Julia; Fu, Jianbo; Khoo, Amanda; Steiner, Sebastian N; Gesell, Martin; Hammer, Jacqueline; Schüffler, Peter J; Salimova, Diyora; Pedrioli, Patrick G A; Wollscheid, Bernd

How Rapidly Does the FAPI PET Signal Reverse Following Therapy? Assessing the FAPI PET Signal in Hypertensive Cardiac Injury and Fibrosis in Mice

治疗后FAPI PET信号逆转的速度如何?评估小鼠高血压性心脏损伤和纤维化中的FAPI PET信号

Hosseini, Atefeh; Haj-Yehia, Elias; Korste, Sebastian; Kuzay, Yalcin; Trajkovic-Arsic, Marija; Settelmeier, Stephan; Cantore, Miriam; Ferenz, Katja B; Siveke, Jens T; Herrmann, Ken; Rassaf, Tienush; Hendgen-Cotta, Ulrike; Weber, Wolfgang A; Varasteh, Zohreh

Safety and Feasibility of Transcatheter Edge-to-Edge Repair of Mitral Regurgitation in Cardiac Amyloidosis

经导管缘对缘修复二尖瓣反流治疗心脏淀粉样变性的安全性和可行性

Vogel, Julia; Luedike, Peter; Hellhammer, Katharina; Settelmeier, Stephan; Jura, Sophia; Buehning, Florian; Lerchner, Tobias; Mondritzki, Thomas; Carpinteiro, Alexander; Reinhardt, H Christian; Schindhelm, Florian; Mahabadi, Amir Abbas; Rassaf, Tienush; Michel, Lars

Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosis

蛋白质遗传药物反应谱分析阐明了骨髓纤维化的可靶向脆弱性

Wildschut, Mattheus H E; Mena, Julien; Dördelmann, Cyril; van Oostrum, Marc; Hale, Benjamin D; Settelmeier, Jens; Festl, Yasmin; Lysenko, Veronika; Schürch, Patrick M; Ring, Alexander; Severin, Yannik; Bader, Michael S; Pedrioli, Patrick G A; Goetze, Sandra; van Drogen, Audrey; Balabanov, Stefan; Skoda, Radek C; Lopes, Massimo; Wollscheid, Bernd; Theocharides, Alexandre P A; Snijder, Berend

Anthracycline Therapy Modifies Immune Checkpoint Signaling in the Heart

蒽环类药物治疗改变心脏的免疫检查点信号

Sebastian Korste, Stephan Settelmeier, Lars Michel, Andrea Odersky, Pia Stock, Fabrice Reyes, Elias Haj-Yehia, Markus S Anker, Anika Grüneboom, Ulrike B Hendgen-Cotta, Tienush Rassaf, Matthias Totzeck

Demonstration of the Early Cardiac Bioavailability of a Non-Specific Cell-Targeted Peptide Using Radionuclide-Based Imaging In Vivo

使用基于放射性核素的体内成像证明非特异性细胞靶向肽的早期心脏生物利用度

Stephan Settelmeier, Zohreh Varasteh, Magdalena Staniszewska, Anna-Lena Beerlage, Fadi Zarrad, Wolfgang P Fendler, Christoph Rischpler, Johannes Notni, Matthias Totzeck, Ken Herrmann, Tienush Rassaf, Ulrike B Hendgen-Cotta

Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology

闪耀受损心脏:核心脏病学聚焦免疫疗法相关心脏毒性

Kersting, David; Settelmeier, Stephan; Mavroeidi, Ilektra-Antonia; Herrmann, Ken; Seifert, Robert; Rischpler, Christoph